Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer
Thomas A. Mace(The Ohio State University), Gregory B. Lesinski(The Ohio State University)
Cited by 16
Related Papers
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
|Gut|2016|540
The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse
|Journal of Clinical Investigation|2003|140
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
|Molecular Cancer|2010|115
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
|Journal for ImmunoTherapy of Cancer|2020|99